NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Search Results for Protease Inhibitors


Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20      Next >


Refine Search
Display Mode: Context | Summary
Concert Pharmaceuticals Initiates Phase 1b Clinical Trial of CTP-518, Protease Inhibitor for Treatment of HIV
2009 NOV 23 ... "Ritonavir co-administration is currently recommended for all marketed HIV protease inhibitors. Our goal is to provide patients with a potent and well-tolerated once-daily therapy ...
Subject: Concert Pharmaceuticals, Inc.
Price: $3.00
*
Nagoya City University reports research in prostate cancer animal studies
2009 NOV 23 ... Health, Oncology, Pathology, Prostate Cancer, Prostate Carcinoma, Prostatic Neoplasms, Protease Inhibitors, Protein Expression, Proteins, Proteomics, Therapy, Treatment. This article ...
Subject: Prostate Cancer Animal Studies
Price: $3.00
*
New findings from University of Wisconsin in the area of inflammation published
2009 NOV 23 ... inflammatory bladder disorders. Mast cell-derived tryptase specifically activates protease-activated receptor-2 (PAR-2), and PAR-2 is known to be involved in inflammation. We ... Keywords: City:Madison, State:WI, Country:United States, Bladder Disorders, COX-2 Inhibitors, Comparative Physiology, Cyclooxygenase, Cyclophosphamide, Drugs, Enzymes, Inflammation, ...
Subject: Inflammation
Price: $3.00
*
No-entry zones for AIDS virus
2009 NOV 29 ... drugs: Reverse transcriptase inhibitors prevent the viral genome from being copied. Protease inhibitors block the maturation of new viral proteins. Scientists agree, however, that the best way ...
Subject: Helmholtz Association of German Research Centres
Price: $3.00
*
Reports outline HIV/AIDS study findings from Y. Yazdanpanah and colleagues
2009 NOV 23 ... Nucleoside Reverse Transcriptase Inhibitor, Pharmaceuticals, Protease Inhibitor, Protease Inhibitors, Proteins, Proteomics, Raltegravir, Ritonavir, Sexually Transmitted Disease, Therapy, ...
Subject: HIV/AIDS
Price: $3.00
*
Reports outline necrosis study results from Pontificia University Catolica of Chile, Faculty of Medicine
2009 NOV 23 ... tissues is mediated by the action of several proteolytic enzymes. Urokinase is a serine protease that plays a key role in connective tissue destruction through conversion of plasminogen ... assessed through western blotting and immunofluorescence using several cell-signaling inhibitors. Tumor necrosis factor-alpha was found to be a strong stimulus for urokinase production ...
Subject: Necrosis
Price: $3.00
*
Researchers at University of East Anglia target biological chemistry
2009 NOV 27 ... Country:United Kingdom, Life Sciences, Diagnosis, Diagnostics, Therapy, Treatment, Protease Inhibitors, Enzymes, Biological Chemistry, Behavior, Microscopy, University of East ...
Subject: Biological Chemistry
Price: $3.00
*
Researchers from University of Munich discuss findings in atopic dermatitis
2009 NOV 23 ... Eczema, Dermatology, Diagnosis, Diagnostics, Enzymes, Genetics, Ichthyosis, Polymerase, Protease Inhibitors, Therapy, Treatment, Venereology, University of Munich. This article was ...
Subject: Atopic Dermatitis
Price: $3.00
*
Schering-Plough Reports Potent Antiviral Activity With Narlaprevir SCH 900518, an Investigational, Once-Daily Protease Inhibitor for Hepatitis C
2009 NOV 16 ... Peginterferon Alfa-2a, Pharmaceutical Business, Pharmaceutical Company, Pharmaceuticals, Protease Inhibitors, Rebetol, Ribavirin, Schering-Plough Corporation, Surgery, Treatment, Viral Inhibition, ...
Subject: Schering-Plough Corporation
Price: $3.00
*
Scientists at Southampton General Hospital publish research in HIV/AIDS
2009 NOV 16 ... receiving nucleoside reverse transcriptase inhibitors (NRTI, n 7), NRTI combined with protease inhibitors (PI; NRTIPI, n 6), in HIV-positive but therapy-naive men (noART, n 5) and in ...
Subject: HIV/AIDS
Price: $3.00
*
Scientists at University of Liege release new data on drug resistance
2009 NOV 23 ... Resistance, Carboxypeptidase, Drug Resistance, Enzymes, Medicinal Chemistry, Protease, Therapy, Treatment, University of Liege. This article was prepared by ... to the beta-lactam antibiotics." "Boronic acids have been developed as inhibitors of the mechanistically related serine beta-lactamases and serine proteases; however, ...
Subject: Drug Resistance
Price: $3.00
*
Scientists at University of Liverpool detail research in HIV/AIDS therapy
2009 NOV 23 ... Enzymes, FDA, HIV, Human Immunodeficiency Virus, Pharmaceuticals, Protease Inhibitor, Protease Inhibitors, Ritonavir, Therapy, Treatment, U.S. Food and Drug Administration, Viral Load, Virology. ...
Subject: HIV/AIDS Therapy
Price: $3.00
*
SCYNEXIS' SCY-635 Demonstrates Positive Antiviral Activity in Combination with Approved and Investigational Anti-HCV Agents
2009 NOV 16 ... investigational non-nucleoside polymerase inhibitors, nucleoside polymerase inhibitors, protease inhibitors, ribavirin and interferon alpha 2b. SCY-635 exhibited additive to synergistic antiviral ...
Subject: SCYNEXIS, Inc.
Price: $3.00
*
Studies from University of Calgary yield new data on antimicrobials
2009 NOV 23 ... killing than the parental strain. ZmpA or ZmpB cleavage of elafin inactivated its anti-protease activity. The effect of ZmpA and ZmpB on the neutrophil proteases elastase and cathepsin ... leukocyte inhibitor, which are antimicrobial peptides as well as neutrophil elastase inhibitors. Both ZmpA and ZmpB cleaved protamine, a fish antimicrobial peptide, and a zmpA zmpB ...
Subject: Antimicrobials
Price: $3.00
*
Studies from University of Queensland describe new findings in medicinal chemistry
2009 NOV 27 ... as inactive zymogens. Factor B is inactive at pH 7, but a catalytically active serine protease under alkaline conditions, enabling structure-activity relationship studies for 63 ... enabling structure-activity relationship studies for 63 substrate-based peptide inhibitors with 4-7 residues and a C-terminal aldehyde. A potent factor B inhibitor was hexpeptide ...
Subject: Medicinal Chemistry
Price: $3.00
*
Twice Daily Oral Medication Shows Promise in Treating Patients with Hepatitis C
2009 NOV 16 ... C Virus, Hepatology, Infectious Disease, Interferon, Liver Disease, Polymerase, Protease Inhibitors, Treatment, Viral Inhibition, Viral Therapy, Virology, American Association for the ...
Subject: Hepatitis C Virus
Price: $3.00
*

Results 1 - 20      Next >




-----------------------
PR Login